![]() | ![]() |
Formats:
|
||||||||||||||||||||
Copyright © 2008 by the Genetics Society of America Functional Interactions Between Sae2 and the Mre11 Complex *Laboratory of Chromosome Biology, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, ‡Rosenstiel Center and Department of Biology, Brandeis University, Waltham, Massachusetts 02454, †Department of Agronomy, Whistler Center for Carbohydrate Research, Purdue University, West Lafayette, Indiana 47907 and §Weill Medical College, Cornell University Graduate School of Medical Sciences, New York, New York 10021 1Corresponding author: Laboratory of Chromosome Biology, MSKCC, 1275 York Ave., RRL 901C, New York, NY 10021. E-mail: petrinij/at/mskcc.org Communicating editor: A. Nicolas Received August 30, 2007; Accepted December 18, 2007. This article has been cited by other articles in PMC.Abstract The Mre11 complex functions in double-strand break (DSB) repair, meiotic recombination, and DNA damage checkpoint pathways. Sae2 deficiency has opposing effects on the Mre11 complex. On one hand, it appears to impair Mre11 nuclease function in DNA repair and meiotic DSB processing, and on the other, Sae2 deficiency activates Mre11-complex-dependent DNA-damage-signaling via the Tel1–Mre11 complex (TM) pathway. We demonstrate that SAE2 overexpression blocks the TM pathway, suggesting that Sae2 antagonizes Mre11-complex checkpoint functions. To understand how Sae2 regulates the Mre11 complex, we screened for sae2 alleles that behaved as the null with respect to Mre11-complex checkpoint functions, but left nuclease function intact. Phenotypic characterization of these sae2 alleles suggests that Sae2 functions as a multimer and influences the substrate specificity of the Mre11 nuclease. We show that Sae2 oligomerizes independently of DNA damage and that oligomerization is required for its regulatory influence on the Mre11 nuclease and checkpoint functions. THE DNA damage response is a highly conserved process that prevents genome instability. In budding yeast, checkpoint signaling is initiated by the yeast ataxia-telangiectasia mutated/ataxia-telangiectasia and Rad3-related (ATM/ATR) homologs, Mec1/Tel1, and is propagated via the effector kinases Chk1 and Rad53 (the Chk2 homolog). DNA damage sites are recognized by two different types of sensors, specific for single-strand DNA (ssDNA) or double-strand breaks (DSBs). RPA (a eukaryotic ssDNA-binding protein) recognizes ssDNA damage sites in cooperation with replication factor C (RFC)-like and PCNA-like (the 9-1-1) complexes. The Mre11 complex consists of three highly conserved members—MRE11, RAD50, and XRS2 (NBS1 in mammals)—and appears to be primarily required for signaling the presence of DSBs (reviewed in Zhou and Elledge 2000; D'Amours and Jackson 2002; Petrini and Stracker 2003; Stracker et al. 2004). Spo11 catalyzes the formation of DSBs to initiate meiotic recombination. In rad50S mutants, Spo11 remains covalently attached at the DSB ends that it forms (Keeney et al. 1997). Sae2Δ cells exhibit the same retention of Spo11 at meiotic DSBs, consistent with the view that, in both mutants, Mre11 nuclease function is impaired (Keeney and Kleckner 1995; McKee and Kleckner 1997; Prinz et al. 1997). This view is supported by the fact that Spo11 retention is also seen in nuclease-deficient alleles of MRE11 (Nairz and Klein 1997; Moreau et al. 1999). In vitro, Mre11 has both endo- and exonuclease activity (D'Amours and Jackson 2002). Mutations of conserved histidine residues (e.g., H125N) in the phsophoesterase domain eliminate both activities; however, in vivo Mre11-H125N has apparently normal exonuclease activity in degrading an HO-endonuclease-generated DSB (Moreau et al. 2001; Lee et al. 2002). These data, and the fact that it is a 3′-5′ exonuclease, support the interpretation that the Mre11 complex is not directly involved in the 5′-3′ resection of DSB ends. Spo11 removal from meiotic DSBs and DNA hairpin cleavage in mitotic cells, both presumably requiring endonuclease activity, are abrogated by Mre11 nuclease deficiency (Lobachev et al. 2002; Yu et al. 2004). rad50S and sae2Δ also affect Mre11 nuclease functions in mitotic cells (Rattray et al. 2001). Both mutations impair the processing of hairpin DNA structures (Lobachev et al. 2002; Yu et al. 2004) and camptothecin (CPT)-induced Top1 cleavage complexes (Vance and Wilson 2002; Deng et al. 2005). These phenotypes are also exhibited by nuclease-deficient mre11 mutants. In addition, rad50S and sae2Δ mutants exhibit synthetic lethality with rad27Δ (FEN1 in human), another flap endonuclease that is required for Okazaki fragment maturation (Debrauwere et al. 2001; Moreau et al. 2001). It has recently been shown that Sae2 itself possesses endonuclease activity, suggesting the possibility that Sae2 may play dual roles: as a regulator of Mre11 nuclease function and/or as a nuclease (Lengsfeld et al. 2007). Previously, we demonstrated that both rad50S and sae2Δ suppress the checkpoint phenotype of Mec1 deficiency via a conserved pathway dependent on the Mre11 complex and Tel1 (referred to as the TM pathway) (Usui et al. 2001, 2006; Morales et al. 2005). sae2Δ also prevents the normal turning off of the DNA damage checkpoint once a DSB is repaired (Clerici et al. 2006). In contrast, overexpression of SAE2 suppresses both MEC1 and TEL1 kinase activity modifying Rad53 and also prevents the damage-induced phosphorylation of Mre11. These observations suggest that Sae2 may be an inhibitory factor for the Mre11-complex checkpoint function. Supporting this possibility, we report here that SAE2 overexpression enhances the methyl methanesulfonate (MMS) sensitivity of mec1Δ rad50S cells, suggesting inhibition of the TM pathway. We have isolated sae2 alleles that fail to enhance this MMS sensitivity and recovered among them sae2 alleles that alter the Mre11 effect on specific types of substrates. For example, the N terminus of Sae2 appears to be required specifically for the Mre11 nuclease to open hairpin DNA structures, but not for Spo11 cleavage. Further, Sae2 appears to function as an oligomer, and self-interaction is correlated with Sae2 influence on the Mre11 complex's nuclease and checkpoint functions. MATERIALS AND METHODS Yeast strains: The following strains are of W303 background (MATa, -α or a/α trp1-1 ura3-1 his3-11,15 leu2-3,112 ade2-1 can1-100 RAD5+, originally from R. Rothstein): JPY2252 (MATa sae2Δ), JPY2253 (MATa FLAG-SAE2), JPY2254 (MATa FLAG-sae2-12), JPY2255 (MATa FLAG-sae2-58), JPY2256 (MATa FLAG-sae2-1), JPY2258 (MATα sae2Δ), JPY2259 (MATα FLAG-SAE2), JPY2261 (MATα FLAG-sae2-1), JPY2262 (MATα FLAG-sae2-12), JPY2264 (MATα FLAG-sae2-58), JPY2290 (MATα FLAG-sae2-51), JPY2308 (MATa/α sae2Δ/sae2Δ), JPY2309 (MATa/α FLAG-SAE2/FLAG-SAE2), JPY2310 (MATa/α FLAG-sae2-1/FLAG-sae2-1), JPY2311 (MATa/α FLAG-sae2-12/FLAG-sae2-12), JPY2312 (MATa/α FLAG-sae2-58/FLAG-sae2-58), JPY2318 (MATa/α sae2Δ/FLAG-sae2-51), JPY2335 (MATa/α rad27Δ/RAD27 sae2Δ/SAE2), JPY2338 (MATa/α rad27Δ/RAD27 FLAG-SAE2 LEU2/SAE2), JPY2339 (MATa/α rad27Δ/RAD27 FLAG-sae2-1 LEU2/SAE2), JPY2340 (MATa/α rad27Δ/RAD27 FLAG-sae2-12 LEU2/SAE2), JPY2344 (MATa/α rad27Δ/RAD27 FLAG-sae2-51 LEU2/SAE2), JPY2345 (MATa/α rad27Δ/RAD27 FLAG-sae2-58 LEU2/SAE2), JPY2518 (MATa FLAG-SAE2 LEU2 mec1Δ sml1Δ), JPY2540 (MATa FLAG-sae2-1 LEU2 mec1Δ sml1Δ), JPY2557 (MATa FLAG-sae2-12 LEU2 mec1Δ sml1Δ), JPY2589 (MATa FLAG-sae2-51 LEU2 mec1Δ sml1Δ), JPY2606 (MATa FLAG-sae2-58 LEU2 mec1Δ sml1Δ), JPY2666 (MATa sae2Δ mec1Δ sml1Δ), JPY2247 (MATa SAE2-HA URA3, YLL1103 from Longhese; Baroni et al. 2004), JPY2248 (MATa SAE2-HA URA3 mec1Δ sml1Δ, DMP380 from Longhese; Baroni et al. 2004). The following strains are of A364a background: JPY319 (MATa WT), JPY321 (MATa mec1-1 sml1), JPY326 (MATa rad50S mec1-1 rad53 sml1), JPY352 (MATa rad50S mec1-1 sml1), JPY847 (MATa rad50S mec1-1 tel1Δ sml1), JPY848 (MATa rad50S sae2Δ mec1-1 sml1), JPY851 (MATa sae2Δ mec1-1 sml1), JPY3009 (MATa mec1-1 sml1 FLAG-SAE2), JPY3010 (MATa mec1-1 sml1 FLAG-sae2-1), and JPY3011 (MATa mec1-1 sml1 FLAG-sae2-12). The following strains are of SK1 background: JPY839 (MATa rad50S sae2ΔTRP1) and JPY840 (MATa sae2). The following strains were used for chromatin immunoprecipitation: JPY1475 (MATa WT hoΔ hmlΔ ADE1 hmrΔ ADE1 ade1 leu2-3,112 lys5 trp1 hisG ura3-52 ade3 GAL HO bar1 ADE3 bar1, H1072 from Lichten; Shroff et al. 2004) and JPY2319 (MATa sae2Δ).Construction of yeast strains: Yeast strains carrying the SAE2 or RAD27 deletion were obtained by PCR disruptions using pFA vectors containing KAN (G418 resistant), HYG (hygromycin resistant), or TRP1 markers. For the integration of sae2 mutants, the SAE2 open reading frame (ORF) was swapped with either a KAN or a HYG marker and FLAG-SAE2 or FLAG-sae2 mutants were integrated at this locus. Deletions and integrations of these genes were verified by PCR. All primers and plasmids used for the mutant constructions and genotyping are available upon request. sae2 mutant screen: JPY352 (rad50S mec1) strains were cotransformed with PCR random-mutagenized FLAG-sae2 fragments and pRS425 vector digested with SacII and KpnI. Transformants were replica plated on media containing 0.007% MMS. rad50S mec1 transformed with empty vector and FLAG-SAE2/2μ were used as controls. The sae2 mutants were screened for the inability to increase MMS sensitivity of rad50S mec1 cells. Approximately 20,000 colonies were screened for this phenotype. To eliminate the mutants that do not express Flag-sae2 proteins, trichloroacetic acid (TCA)-extracted whole proteins were prepared and expression of sae2 mutants was analyzed by Western blot using a monoclonal Flag-antibody. FLAG-sae2 mutant plasmids were then rescued from these cells. The MMS sensitivity and protein expression of these clones were reverified. A total of 15 sae2 mutants were isolated and sequenced. To compensate for the bias in screening, due to the N-terminal tagging of Sae2, Sae2 was tagged at the C terminus with HA. Three N-terminal truncation alleles, sae2-82, sae2-139, and sae2-146, were isolated by the C-terminal HA tagging. These were N-terminal 120-amino-acid truncation mutants (referred to as a sae2-ΔN120). In addition, two N-terminal truncations, sae2-ΔN170 and -ΔN225, were also generated. Analysis of MMS, UV, and CPT sensitivity: Fresh growing cells were serially diluted and spotted onto solid media containing different concentrations of indicated drugs or irradiated with indicated UV doses. Plates were photographed after 3 days of incubation at 30°. For the transient treatment, exponentially growing cells were untreated or treated with the indicated concentrations of drugs and the same number of cells was spotted onto a YPD plate. The percentage of viability was determined by counting colonies after 3 days of incubation. Immunoprecipitation and Western blot analysis: About 5 × 108 cells were lysed in lysis buffer [25 mm Tris–HCl (pH 7.5), 1 mm EDTA, 0.5% NP-40, 10% glycerol, 1 mm phenylmethylsulfonyl fluoride, 1 mm dithiothreitol, 1× complete and 150 mm NaCl] using FASTprep (Q-BIOgene). Extracts were immunoprecipitated with HA or Flag antibody. Coprecipitated proteins were analyzed by Western blot. Chromatin immunoprecipitation and real-time PCR: Cell extracts were prepared as described (Shroff et al. 2004) and immunoprecipitated with anti-Mre11 serum. The precipitated DNA was quantitated by real-time PCR using the 7900HT (Applied Biosystems, Foster City, CA) and Light Cycler 480 sequence detection system (Roche). Amplified double-stranded DNA product during 40 cycles was detected by SYBR Green I. All measurement of PCR product was quadruplicated and compared with 1000-fold linear range standard DNA controls prepared from the wild-type strain. Efficiency of Mre11 association with a HO break, 0.05 and 66 kb from the break, was obtained by normalizing the chromatin-immunoprecipitated DNA to input DNA. The sequences of primers used for the real-time PCR are available upon request. Checkpoint, adaptation, and recovery assays: For G2/M checkpoint assays, cells were arrested in G1 with α-factor and released into 0.02% or 0.03% MMS. Cells were collected at the indicated time points and stained with DAPI. The percentage of nuclear division was assessed as described (Usui et al. 2001). YMV80 sae2Δ cells transformed with the sae2 plasmids (CEN) were assayed for repair and recovery after a single HO–DSB induction. To assay G2/M arrest and recovery, cells were grown overnight either in YEP–lactate media or in synthetic media plus raffinose at 30°. Galactose was added to the liquid culture to a final concentration of 2% and the culture was incubated at 30° for a further 6 hr. Cells were then spread onto YEP–galactose plates and incubated at 30° overnight. At 24 hr the plates were examined for the percentage of cells that were still arrested as G2/M dumbbells, as an indication of failed repair or delayed recovery. In parallel, samples were plated directly from preinduction media onto YEPD and YEP–galactose plates to determine the percentage of viability. Telomere Southern blot: XhoI-digested genomic DNA was analyzed for telomere length by Southern blot hybridizing 32P-labeled telomere oligo probes. Analysis of meiotic DSB processing: Following 4.5 and 9 hr in sporulation media, EcoRI-digested genomic DNA was assayed for meiotic DSB processing at the THR4 locus by Southern blot. RESULTS Sae2 blocks the TM pathway: We showed previously that Sae2 deficiency suppresses the MMS sensitivity of mec1 mutants (Usui et al. 2001) through the TM pathway, which suggests that Sae2 may antagonize Mre11-complex checkpoint or DNA repair functions. This view predicts that SAE2 overexpression would increase the sensitivity of mec1 and rad50S mec1 cells to genotoxic stress. To test this idea, Flag-epitope-tagged SAE2 in a high-copy (2μ) or in a low-copy (CEN) plasmid was introduced into sae2Δ strains that were otherwise wild type, rad50S, mec1, or rad50S mec1. High-copy plasmid produced at least five times more Flag-Sae2 proteins compared to SAE2/CEN (Figure 1B
The effect of SAE2 overexpression on mec1 and rad50S mec1 cells reflected an effect on the TM pathway. SAE2 overexpression was carried out in rad50S mec1 rad53Δ and rad50S mec1 tel1Δ mutants; both Rad53 and Tel1 deficiency block the TM pathway (Usui et al. 2001). SAE2 overexpression did not further increase the MMS sensitivity of rad50S mec1 cells lacking either RAD53 or TEL1 (Figure 1, C and D Both the Mre11 complex and Tel1 influence telomere maintenance (Ritchie and Petes 2000; D'Amours and Jackson 2002; Lundblad 2002; Pandita 2002; d'Adda di Fagagna et al. 2003). sae2Δ cells exhibited slightly elongated telomeres and caused further telomere elongation in combination with a mec1 mutation, similar to observations of rad50S cells (Kironmai and Muniyappa 1997; data not shown). This telomere lengthening was dependent on TEL1, again suggesting a dependence on the TM pathway (data not shown). Thus, we examined whether SAE2 overexpression inhibited telomere lengthening, but found that SAE2 overexpression did not affect telomere length, regardless of the genotypes (Figure 1F Sae2 influences DNA repair events that require the Mre11 nuclease: To gain mechanistic insight regarding the functional interaction between Sae2 and the Mre11 complex, we mutagenized SAE2 and screened for alleles that failed to sensitize rad50S mec1 cells to MMS. Approximately 20,000 colonies of rad50S mec1 strains transformed with randomly mutagenized FLAG-sae2 fragments were tested on solid media containing 0.007% MMS. Fifteen alleles were isolated (Figure 2C
sae2Δ phenocopies Mre11 nuclease deficiency in the repair of CPT-induced DNA damage, the metabolism of DNA hairpins, the processing of meiotic DSBs, and synergism with rad27Δ (Cao et al. 1990; Keeney and Kleckner 1995; Nairz and Klein 1997; Prinz et al. 1997; Debrauwere et al. 2001; Moreau et al. 2001; Lobachev et al. 2002; Vance and Wilson 2002; Yu et al. 2004; Deng et al. 2005). As each of these contexts are likely to require the metabolism of distinct DNA lesions, we asked whether any of the sae2 alleles obtained were separation-of-function mutants that affected some Mre11-dependent processes while leaving others intact. sae2 alleles were integrated at the SAE2 locus and analyzed as described below. The data obtained are summarized in Table 1. sae2-12 and sae2-58 strains exhibited MMS and CPT sensitivity comparable to sae2Δ, whereas sae2-1 and sae2-51 were indistinguishable from wild type in this regard (Figure 3A
sae2Δ did not suppress the mec1 growth defect in response to CPT, in contrast to MMS treatment (Figure 3B To examine whether the sae2 mutants were proficient in Spo11 removal from meiotic DSBs, diploid W303 cells homozygous for each of the sae2 alleles were examined for DSB processing (Figure 3C The Mre11 nuclease and Sae2 are required to open DNA hairpin structures (Lobachev et al. 2002; Yu et al. 2004). To examine the ability of the sae2 mutants to process hairpin structures, we took advantage of a transposition assay system in budding yeast. In this assay strain (Weil and Kunze 2000), a maize Ds transposon is inserted in the middle of the ADE2 ORF. Expression of the maize Ac transposase excises the Ds element and leaves a hairpin at the ends of the adjacent chromosomal DNA. These hairpins have to open to be repaired by DSB repair pathways. Repair efficiency can be estimated by the frequency of Ade+ revertants. sae2Δ strains carrying sae2 mutant plasmids (2μ) were examined for the frequency of Ade+ revertants (Table 1 and supplemental Table S1 at http://www.genetics.org/supplemental/). SAE2 gave ~37.0 revertants/107 cells whereas sae2-12, sae2-58, or empty vector transformants gave 2.0, 8.3, or 0 revertants, respectively. sae2-1 (41.5/107) was similar to wild type. Although sae2-51 behaved as wild type with respect to checkpoint regulation and to MMS and CPT sensitivity as well as meiotic progression (Table 1; supplemental Table S1 and Figure S2 at http://www.genetics.org/supplemental/), this allele exhibited a severe hairpin repair defect (1.7/107). sae2-51 contains a E24V mutation, indicating that the N-terminal end of Sae2 may be specifically required for the Mre11 nuclease to open hairpin DNA. We note that another N-terminal mutant, sae2-58, also cannot process hairpin ends. Mutations that impair Mre11 nuclease function in vivo, such as sae2Δ and mre11-H125N, are synthetically lethal with Rad27 deficiency (Debrauwere et al. 2001; Moreau et al. 2001). Synthetic lethality between rad27Δ and sae2 mutants was analyzed by tetrad dissection. sae2-12 and sae2-58 were each lethal with rad27Δ, but sae2-1 rad27Δ and sae2-51 rad27Δ double mutants were viable (Table 1). Role of Sae2 in checkpoint activation and inactivation: Upon MMS treatment, wild-type cells arrest in G2/M, whereas checkpoint-deficient mec1 mutants fail to arrest and undergo nuclear division accompanied by loss of viability. We showed that sae2Δ suppresses the checkpoint defects associated with Mec1 deficiency (Usui et al. 2001). Integrated sae2-1, sae2-12, and sae2-58 were assayed for the rescue of the G2/M checkpoint defect of mec1 cells. G1-arrested cells were released into MMS and binucleated cells were counted every 30 min. As shown in Figure 4A
When DNA damage is repaired, cells must inactivate checkpoint pathways to resume the cell cycle; this is defined as recovery from checkpoint arrest (Lee et al. 1998; Pellicioli et al. 2001; Vaze et al. 2002; Leroy et al. 2003). It has recently been shown that sae2Δ cells are defective for recovery from arrest induced by a long-lived HO-endonuclease-mediated DNA break (Clerici et al. 2006). Accordingly, we examined the panel of sae2 mutants for their ability to recover from checkpoint arrest. In strain YMV80, DSBs induced by HO endonuclease are repaired by single-strand annealing (SSA) ~6 hr after HO induction (Vaze et al. 2002). The DNA damage checkpoint is fully activated in 2 hr after the HO-DSB formation but is turned off for cells to resume cell cycle progression when SSA is completed. YMV80 sae2Δ cells were transformed with the sae2 plasmids (CEN) and then assayed for recovery after HO induction by determining the percentage of cells with dumbbell shape, indicative of cells that are permanently arrested in G2. sae2Δ cells carrying a SAE2 plasmid maintained 88% viability (Figure 4B In contrast to results reported by Clerici et al. (2006), the recovery defect of sae2Δ was rescued by tel1Δ. Recovery was also rescued by C-terminal mutation of Xrs2 that fails to associate the Mre11 complex with Tel1, xrs2-664 (Shima et al. 2005). Finally, the recovery defect of sae2Δ was suppressed by PTC2 overexpression (a regulator subunit of phosphatase) and mec1Δ, both of which prevent maintenance of Rad53 phosphorylation (Figure 4C Influence of Sae2 on Mre11–DSB association: Physical association of the Mre11 complex with DSBs is vital for its function in checkpoint activation as well as in meiosis (Usui et al. 2001; Petrini and Stracker 2003; Borde et al. 2004; Lisby et al. 2004; Shroff et al. 2004). Therefore, we hypothesized that the inhibition of the TM pathway by SAE2 overexpression limits Mre11 association with DSBs. Indirect evidence for this possibility comes from the apparent requirement for Sae2 in the formation of Mre11 “repair” foci (Lisby et al. 2004; Clerici et al. 2006). To test this hypothesis, we carried out chromatin immunoprecipitation (ChIP) experiments to assess Mre11-complex association at an HO break in a hmrΔ hmlΔ strain to prevent repair by gene conversion (Shroff et al. 2004). Wild-type and sae2Δ cell extracts were immunoprecipitated with anti-Mre11 serum, and Mre11 association at 0.05 kb from the HO break was determined by quantitative PCR. As previously reported (Lisby et al. 2004; Clerici et al. 2006), Mre11 associated with a HO break two to three times more efficiently in sae2Δ cells, compared to wild type, although Sae2 deficiency did not change the association and dissociation kinetics (Figure 5
Sae2 self-interaction via two domains is critical for its cellular functions: Sae2–Sae2 interaction was observed in a global analysis of two-hybrid interactions (Ito et al. 2001). To determine whether the phenotypes of our sae2 mutant panel could be associated with compromised self-association, we constructed diploid strains carrying integrated FLAG-SAE2 and SAE2-HA and examined their interaction by co-immunoprecipitation (co-IP) experiments. Cells were either untreated or treated with 0.03% MMS for 2 hr and extracts were immunoprecipitated with anti-HA or anti-Flag antibody. As shown in Figure 6A
To determine whether this interaction remains intact in sae2 mutants, we performed co-IP experiments in diploid strains carrying integrated SAE2-HA and FLAG-sae2 mutants. As shown in Figure 6B To further test the N-terminal domain of Sae2 in the self-interaction, we generated three N-terminal truncation mutants with a C-terminal HA tag (sae2-ΔN120, -ΔN170, and -ΔN225). Unexpectedly, sae2-ΔN120, which lost L25, pulled down wild-type Sae2 and sae2-12 (lanes 5 and 6), while sae2-Δ170 did not (lanes 7 and 8), demonstrating that the additional region between residues 120 and 170 is required for the interaction (Figure 6E DISCUSSION The genetic relationship between Sae2 and the Mre11 complex suggests that Sae2 may antagonize checkpoint regulation, while, on the other hand, enhancing Mre11 nuclease functions. In this study, we find evidence that the association of the Mre11 complex with DSB ends may be influenced by Sae2, but this does not appear to be the basis of the Sae2 effect on checkpoint signaling. The sae2 mutant panel confirms the influence on the DNA repair functions of the Mre11 complex and contains separation-of-function alleles that parse the influence on the Mre11 nuclease in substrate-specific manner. Finally, the data demonstrate that Sae2 self-interaction and oligomerization are critical to its function. Specificity of Sae2 regulation of the Mre11 complex nuclease function: As summarized in Table 1, we observed a consistent correlation between sae2 phenotypes in CPT sensitivity and the defects in processing of Spo11-DNA intermediates. Both these contexts presumably require the cleavage of DNA with protein covalently attached to it, suggesting that the Mre11-complex-dependent aspects of such cleavage events are strictly dependent upon Sae2. Alleles in this class are also synthetically lethal with Rad27 deficiency, further suggesting that the impairment of Mre11 nuclease function engendered by these sae2 alleles exacerbates the effects of DNA lesions stabilized by the absence of Rad27. The sae2-51 allele (E24V) suggests that the influence of Sae2 on Mre11-complex-dependent hairpin cleavage may be mechanistically distinct. This allele exhibited severe defects in hairpin DNA repair, whereas it was proficient for other functions and did not exhibit MMS and CPT sensitivity, defects in Spo11 cleavage, or synthetic lethality with rad27Δ (Table 1, Figure 3 Despite failing to inhibit the TM pathway when overexpressed, the sae2-1 allele appeared to be wild type for most phenotypes (Figure 3 The only region of Sae2 that exhibits any conservation is at the C terminus (Figure 7A
Role of Sae2 in TM pathway: The genetic interaction between SAE2 and the Mre11 complex strongly suggests that they may physically interact. We can reproducibly co-immunoprecipitate Sae2 with components of the Mre11 complex, but this apparent interaction requires the presence of DNA (data not shown). Interestingly, upon cell fractionation, the majority of Sae2 was found associated with chromatin; hence, it remains a possibility that Sae2 and the Mre11 complex physically associate on chromatin. Mre11 associates more efficiently with DSB sites in the absence of Sae2 (Figure 5 Higher-order structure of Sae2: Sae2 has two interaction domains in the N-terminal half, a region around L25 (domain A) and a region between 120 and 170 amino acids (domain B). Co-immunoprecipitation data (Figure 6 We favor the idea that Sae2 mulitmerizes as opposed to simple dimerization. The affect of overexpressing sae2 mutations in rad50S mec1Δ cells is influenced by the presence of a wild-type SAE2 gene on the chromosome. For example, the rescue of mec1Δ MMS sensitivity by rad50S was not inhibited by sae2-1 overexpression (Figure 2A Alternatively, Sae2 may dimerize first and then self-assemble to form higher-order structure (Figure 7C, iii A putative SAE2 homolog, CtIP, has recently been identified in humans, worms, and plants (Penkner et al. 2007; Sartori et al. 2007; Uanschou et al. 2007). CtIP has sequence homology to budding yeast SAE2 at the C-terminal region, a small domain that is conserved in several fungal species. Similar to sae2Δ, CtIP deficiency is associated with defects in processing of meiotic DSBs, and evidence for alteration in the processing of mitotic DSBs has been presented and CtIP appears to be required for recruitment of ATR in human cells (Sartori et al. 2007). The data presented here shed light on Sae2's mechanisms of action and illustrate that its influence on nuclease activities required for DSB metabolism varies according to the substrate, as well as the status of the checkpoint pathway. Acknowledgments We thank Maria Pia Longhese for the SAE2-HA strain and Michael Lichten for yeast strains for chromatin immunoprecipitation experiments; Gene Bryant and Daniel Spagna in the Mark Ptashne lab for technical help for real-time PCR; and the members of our labs for insightful discussion over the course of this work. This work was supported by grants GM56888 and GM59413 and the Joel and Joan Smilow Initiative (J.H.J.P.), grant GM61766 (J.E.H.) and National Science Foundation MCB-0344655, and Binational Agriculture Research and Development award IS-372305 (C.W.). References
|
PubMed related articles
Your browsing activity is empty. Activity recording is turned off. |
|||||||||||||||||||
Nature. 2000 Nov 23; 408(6811):433-9.
[Nature. 2000]Nat Rev Mol Cell Biol. 2002 May; 3(5):317-27.
[Nat Rev Mol Cell Biol. 2002]Trends Cell Biol. 2003 Sep; 13(9):458-62.
[Trends Cell Biol. 2003]DNA Repair (Amst). 2004 Aug-Sep; 3(8-9):845-54.
[DNA Repair (Amst). 2004]Cell. 1997 Feb 7; 88(3):375-84.
[Cell. 1997]Proc Natl Acad Sci U S A. 1995 Nov 21; 92(24):11274-8.
[Proc Natl Acad Sci U S A. 1995]Genetics. 1997 Jul; 146(3):797-816.
[Genetics. 1997]Genetics. 1997 Jul; 146(3):781-95.
[Genetics. 1997]Genes Dev. 1997 Sep 1; 11(17):2272-90.
[Genes Dev. 1997]Nat Rev Mol Cell Biol. 2002 May; 3(5):317-27.
[Nat Rev Mol Cell Biol. 2002]Genetics. 2001 Dec; 159(4):1423-33.
[Genetics. 2001]DNA Repair (Amst). 2002 Jan 22; 1(1):27-40.
[DNA Repair (Amst). 2002]Cell. 2002 Jan 25; 108(2):183-93.
[Cell. 2002]Mol Cell Biol. 2004 Feb; 24(3):1351-64.
[Mol Cell Biol. 2004]Genetics. 2001 May; 158(1):109-22.
[Genetics. 2001]Cell. 2002 Jan 25; 108(2):183-93.
[Cell. 2002]Mol Cell Biol. 2004 Feb; 24(3):1351-64.
[Mol Cell Biol. 2004]Proc Natl Acad Sci U S A. 2002 Oct 15; 99(21):13669-74.
[Proc Natl Acad Sci U S A. 2002]Genetics. 2005 Jun; 170(2):591-600.
[Genetics. 2005]Mol Cell. 2001 Jun; 7(6):1255-66.
[Mol Cell. 2001]Exp Cell Res. 2006 Aug 15; 312(14):2694-9.
[Exp Cell Res. 2006]Genes Dev. 2005 Dec 15; 19(24):3043-54.
[Genes Dev. 2005]EMBO Rep. 2006 Feb; 7(2):212-8.
[EMBO Rep. 2006]Mol Cell Biol. 2004 May; 24(10):4151-65.
[Mol Cell Biol. 2004]Curr Biol. 2004 Oct 5; 14(19):1703-11.
[Curr Biol. 2004]Curr Biol. 2004 Oct 5; 14(19):1703-11.
[Curr Biol. 2004]Mol Cell. 2001 Jun; 7(6):1255-66.
[Mol Cell. 2001]Mol Cell. 2001 Jun; 7(6):1255-66.
[Mol Cell. 2001]Mol Cell. 2001 Jun; 7(6):1255-66.
[Mol Cell. 2001]Genetics. 2000 May; 155(1):475-9.
[Genetics. 2000]Nat Rev Mol Cell Biol. 2002 May; 3(5):317-27.
[Nat Rev Mol Cell Biol. 2002]Oncogene. 2002 Jan 21; 21(4):522-31.
[Oncogene. 2002]Oncogene. 2002 Jan 21; 21(4):611-8.
[Oncogene. 2002]Nature. 2003 Nov 13; 426(6963):194-8.
[Nature. 2003]Cell. 1990 Jun 15; 61(6):1089-101.
[Cell. 1990]Proc Natl Acad Sci U S A. 1995 Nov 21; 92(24):11274-8.
[Proc Natl Acad Sci U S A. 1995]Genes Dev. 1997 Sep 1; 11(17):2272-90.
[Genes Dev. 1997]Genetics. 1997 Jul; 146(3):781-95.
[Genetics. 1997]Proc Natl Acad Sci U S A. 2001 Jul 17; 98(15):8263-9.
[Proc Natl Acad Sci U S A. 2001]Cell. 2002 Jan 25; 108(2):183-93.
[Cell. 2002]Mol Cell Biol. 2004 Feb; 24(3):1351-64.
[Mol Cell Biol. 2004]Nat Genet. 2000 Oct; 26(2):187-90.
[Nat Genet. 2000]Proc Natl Acad Sci U S A. 2001 Jul 17; 98(15):8263-9.
[Proc Natl Acad Sci U S A. 2001]Genetics. 2001 Dec; 159(4):1423-33.
[Genetics. 2001]Mol Cell. 2001 Jun; 7(6):1255-66.
[Mol Cell. 2001]Cell. 1998 Aug 7; 94(3):399-409.
[Cell. 1998]Mol Cell. 2001 Feb; 7(2):293-300.
[Mol Cell. 2001]Mol Cell. 2002 Aug; 10(2):373-85.
[Mol Cell. 2002]Mol Cell. 2003 Mar; 11(3):827-35.
[Mol Cell. 2003]EMBO Rep. 2006 Feb; 7(2):212-8.
[EMBO Rep. 2006]EMBO Rep. 2006 Feb; 7(2):212-8.
[EMBO Rep. 2006]Genetics. 2005 May; 170(1):71-85.
[Genetics. 2005]Mol Cell. 2001 Jun; 7(6):1255-66.
[Mol Cell. 2001]Trends Cell Biol. 2003 Sep; 13(9):458-62.
[Trends Cell Biol. 2003]Mol Cell. 2004 Feb 13; 13(3):389-401.
[Mol Cell. 2004]Cell. 2004 Sep 17; 118(6):699-713.
[Cell. 2004]Curr Biol. 2004 Oct 5; 14(19):1703-11.
[Curr Biol. 2004]Proc Natl Acad Sci U S A. 2001 Apr 10; 98(8):4569-74.
[Proc Natl Acad Sci U S A. 2001]Mol Cell. 2007 Nov 30; 28(4):638-51.
[Mol Cell. 2007]Mol Cell Biol. 2004 May; 24(10):4151-65.
[Mol Cell Biol. 2004]Cell. 2004 Sep 17; 118(6):699-713.
[Cell. 2004]Cell. 1991 May 31; 65(5):765-74.
[Cell. 1991]FASEB J. 1993 Jul; 7(10):944-50.
[FASEB J. 1993]Mol Cell Biol. 1994 Aug; 14(8):5182-91.
[Mol Cell Biol. 1994]Nat Rev Microbiol. 2004 May; 2(5):391-400.
[Nat Rev Microbiol. 2004]Nat Struct Biol. 2003 Mar; 10(3):212-8.
[Nat Struct Biol. 2003]J Mol Biol. 1996 Oct 25; 263(2):149-62.
[J Mol Biol. 1996]Nucleic Acids Res. 2000 Sep 15; 28(18):3504-10.
[Nucleic Acids Res. 2000]J Mol Biol. 2002 Dec 6; 324(4):841-50.
[J Mol Biol. 2002]EMBO J. 2007 Dec 12; 26(24):5071-82.
[EMBO J. 2007]Nature. 2007 Nov 22; 450(7169):509-14.
[Nature. 2007]EMBO J. 2007 Dec 12; 26(24):5061-70.
[EMBO J. 2007]